Sign In
Buy SAN
$14.10
-0.0100 (-0.0709%)
At Close: Jul 31, 2026
Spain's Santander Q1 profit rises 58% compared to same period a year ago
01:09am, Tuesday, 26'th Apr 2022
Spain's Santander on Tuesday said its net profit in the first quarter rose 58% compared to the same period a year ago thanks to a recovery in Europe and a solid performance in South America.
Santander to close branches early as it transitions towards digital banking
09:25am, Thursday, 21'st Apr 2022
Santander UK will close most of its branches at 3 pm on weekdays as part of a shift towards digital banking. Branches will operate between 9.30 am and 3 pm on weekdays, and from 9 am to 12.30 pm on Sa
The recovery will be uneven in banking, Oliver Wyman's O'Kelly says
02:14am, Thursday, 21'st Apr 2022
Ronan O'Kelly, European head of corporate and institutional banking at Oliver Wyman, discusses its latest review of the banking sector.
Santander's East Midtown tower has new owner with modern vision
03:45pm, Sunday, 17'th Apr 2022
East Midtown, a favored location for hedge funds and small financial firms, will soon have a prestigious new location for them. After serving as Santander's New York headquarters since 1991, the 134,0
Communiqué de presse: Publication, dans le New England Journal of Medicine, des résultats positifs de phase I/II du rilzabrutinib dans le traitement de la thrombocytopénie immune
05:00am, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
Publication, dans le New England Journal of Medicine, des résultats positifs de phase I/II du rilzabrutinib dans le traitement de la thrombocytopénie immune
Press Release: Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine
05:00am, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine
Santander Bank Debuts Santander eLockBox to Consolidate Digital Payments
03:38pm, Wednesday, 13'th Apr 2022
Banking giant Santander Bank, N.A. on Wednesday (April 13) launched Santander eLockBox, an electronic lockbox that consolidates businesses' incoming digital payments and simplifies electronic receivab
Sanofi - AGM 03.05.2022 - Availability of Preparatory Documents
04:25pm, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
COMBINED GENERAL MEETING OF MAY 3, 2022
Sanofi - AGM 03.05.2022 - Mise à disposition des documents préparatoires
04:25pm, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
ASSEMBLEE GENERALE MIXTE DU 3 MAI 2022
Communiqué de presse: La Commission européenne approuve Dupixent® (dupilumab) pour le traitement des enfants âgés de 6 à 11 ans présentant un asthme sévère avec signature inflammatoire de type 2
05:00am, Thursday, 07'th Apr 2022 GlobeNewswire Inc.
La Commission européenne approuve Dupixent® (dupilumab) pour le traitement des enfants âgés de 6 à 11 ans présentant un asthme sévère avec signature inflammatoire de type 2
Press Release: Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation
05:00am, Thursday, 07'th Apr 2022 GlobeNewswire Inc.
Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation
Communiqué de presse: La FDA accepte d’accorder un examen prioritaire à Dupixent® (dupilumab) pour le traitement des patients de 12 ans et plus souffrant d’œsophagite à éosinophiles
05:00am, Monday, 04'th Apr 2022 GlobeNewswire Inc.
La FDA accepte d’accorder un examen prioritaire à Dupixent® (dupilumab) pour le traitement des patients de 12 ans et plus souffrant d’œsophagite à éosinophiles
Press Release: FDA accepts Dupixent® (dupilumab) for Priority Review in patients aged 12 years and older with eosinophilic esophagitis
05:00am, Monday, 04'th Apr 2022 GlobeNewswire Inc.
FDA accepts Dupixent® (dupilumab) for Priority Review in patients aged 12 years and older with eosinophilic esophagitis
Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022
02:17pm, Friday, 01'st Apr 2022 Benzinga
Upgrades
For Banco Santander SA (NYSE:SAN), Credit Suisse upgraded the previous rating of Neutral to Outperform. Banco Santander earned $0.14 in the fourth quarter, compared to $0.09 in the year-ago q
Santander's 2022 targets on track as Americas help
06:29am, Friday, 01'st Apr 2022
Spain's Santander on Friday said it was on track to meet its 2022 profitability target and maintained its mid-term goals thanks to solid performance in the Americas and a recovery in Europe.
